Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Cited by 178

The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.

Safety of Outpatient Closed-Loop Control: First Randomized Crossover Trials of a Wearable Artificial Pancreas

Open access
Kovatchev, Boris P., Renard, Eric, Cobelli, Claudio, Zisser, Howard C., Keith-Hynes, Patrick, Anderson, Stacey M., Brown, Sue A., Chernavvsky, Daniel R., Breton, Marc D., Mize, Lloyd B., Farret, Anne, Place, Jérôme, Bruttomesso, Daniela, Del Favero, Simone, Boscari, Federico, Galasso, Silvia, Avogaro, Angelo, Magni, Lalo, Di Palma, Federico, Toffanin, Chiara, Messori, Mirko, Dassau, Eyal, Doyle, Francis J. · 2014 · Diabetes Care

Abstract

OBJECTIVE: We estimate the effect size of hypoglycemia risk reduction on closed-loop control (CLC) versus open-loop (OL) sensor-augmented insulin pump therapy in supervised outpatient setting. RESEARCH DESIGN AND METHODS: Twenty patients with type 1 diabetes initiated the study at the Universities of Virginia, Padova, and Montpellier and Sansum Diabetes Research Institute; 18 completed the entire protocol. Each patient participated in two 40-h outpatient sessions, CLC versus OL, in randomized order. Sensor (Dexcom G4) and insulin pump (Tandem t:slim) were connected to Diabetes Assistant (DiAs)—a smartphone artificial pancreas platform. The patient operated the system through the DiAs user interface during both CLC and OL; study personnel supervised on site and monitored DiAs remotely. There were no dietary restrictions; 45-min walks in town and restaurant dinners were included in both CLC and OL; alcohol was permitted. RESULTS: The primary outcome—reduction in risk for hypoglycemia as measured by the low blood glucose (BG) index (LGBI)—resulted in an effect size of 0.64, P = 0.003, with a twofold reduction of hypoglycemia requiring carbohydrate treatment: 1.2 vs. 2.4 episodes/session on CLC versus OL (P = 0.02). This was accompanied by a slight decrease in percentage of time in the target range of 3.9–10 mmol/L (66.1 vs. 70.7%) and increase in mean BG (8.9 vs. 8.4 mmol/L; P = 0.04) on CLC versus OL. CONCLUSIONS: CLC running on a smartphone (DiAs) in outpatient conditions reduced hypoglycemia and hypoglycemia treatments when compared with sensor-augmented pump therapy. This was accompanied by marginal increase in average glycemia resulting from a possible overemphasis on hypoglycemia safety.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.2337/dc13-2076

Cites

2 of 2 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 2 references

Research works printed but not linked: 20

  1. Cobelli, 2011, Artificial pancreas: past, present, future, Diabetes, 60, 2672, 10.2337/db11-0654 · DOI · Paper page
  2. Weinzimer, 2008, Fully automated closed-loop insulin delivery versus semiautomated hybrid control in pediatric patients with type 1 diabetes using an artificial pancreas, Diabetes Care, 31, 934, 10.2337/dc07-1967 · DOI · Paper page
  3. Bruttomesso, 2009, Closed-loop artificial pancreas using subcutaneous glucose sensing and insulin delivery and a model predictive control algorithm: preliminary studies in Padova and Montpellier, J Diabetes Sci Tech, 3, 1014, 10.1177/193229680900300504 · DOI
  4. Hovorka, 2010, Manual closed-loop insulin delivery in children and adolescents with type 1 diabetes: a phase 2 randomised crossover trial, Lancet, 375, 743, 10.1016/S0140-6736(09)61998-X · DOI · Paper page
  5. El-Khatib, 2010, A bihormonal closed-loop artificial pancreas for type 1 diabetes, Sci Transl Med, 2, 27ra27, 10.1126/scitranslmed.3000619 · DOI · Paper page
  6. Atlas, 2010, MD-logic artificial pancreas system: a pilot study in adults with type 1 diabetes, Diabetes Care, 33, 1072, 10.2337/dc09-1830 · DOI · Paper page
  7. Renard, 2010, Closed-loop insulin delivery using subcutaneous infusion and glucose sensing, and equipped with a dedicated safety supervision algorithm, improves safety of glucose control in type 1 diabetes, Diabetologia, 53, S25
  8. Dassau, 2013, Diabetes Care, 36, 801, 10.2337/dc12-0948 · DOI
  9. Phillip, 2013, Nocturnal glucose control with an artificial pancreas at a diabetes camp, N Engl J Med, 368, 824, 10.1056/NEJMoa1206881 · DOI · Paper page
  10. Nimri, 2013, Night glucose control with MD-Logic artificial pancreas in home setting: a single blind, randomized crossover trial-interim analysis, Pediatr Diabetes
  11. Keith-Hynes, 2013, DiAs user interface: a patient-centric interface for mobile artificial pancreas systems, J Diabetes Sci Tech, 7, 1416, 10.1177/193229681300700602 · DOI
  12. O’Grady, 2012, The use of an automated, portable glucose control system for overnight glucose control in adolescents and young adults with type 1 diabetes, Diabetes Care, 35, 2182, 10.2337/dc12-0761 · DOI
  13. Cobelli, 2012, Pilot studies of wearable outpatient artificial pancreas in type 1 diabetes, Diabetes Care, 35, e65, 10.2337/dc12-0660 · DOI
  14. Kovatchev, 2013, Feasibility of outpatient fully integrated closed-loop control: first studies of wearable artificial pancreas, Diabetes Care, 36, 1851, 10.2337/dc12-1965 · DOI · Paper page
  15. Kovatchev, 1998, Assessment of risk for severe hypoglycemia among adults with IDDM: validation of the low blood glucose index, Diabetes Care, 21, 1870, 10.2337/diacare.21.11.1870 · DOI · Paper page
  16. Place, 2013, DiAs web monitoring: a real-time remote monitoring system designed for artificial pancreas outpatient trials, J Diabetes Sci Tech, 7, 1427, 10.1177/193229681300700603 · DOI
  17. Patek, 2012, Modular closed-loop control of diabetes, IEEE Trans Biomed Eng, 59, 2986, 10.1109/TBME.2012.2192930 · DOI · Paper page
  18. Hughes, 2010, Hypoglycemia prevention via pump attenuation and red-yellow-green “traffic” lights using continuous glucose monitoring and insulin pump data, J Diabetes Sci Technol, 4, 1146, 10.1177/193229681000400513 · DOI
  19. Ellingsen, 2009, Safety constraints in an artificial pancreatic beta cell: an implementation of model predictive control with insulin on board, J Diabetes Sci Technol, 3, 536, 10.1177/193229680900300319 · DOI
  20. Soru, 2012, Annu Rev Contr, 36, 118, 10.1016/j.arcontrol.2012.03.009 · DOI

Cited by

Metadata

Authors
Kovatchev, B. P., Renard, E., Cobelli, C., Zisser, H. C., Keith-Hynes, P., Anderson, S. M., Brown, S. A., Chernavvsky, D. R., Breton, M. D., Mize, L. B., Farret, A., Place, J., Bruttomesso, D., Del Favero, S., Boscari, F., Galasso, S., Avogaro, A., Magni, L., Di Palma, F., Toffanin, C., Messori, M., Dassau, E., & Doyle, F. J.
Venue
Diabetes Care
Published
2014-06-12
Volume
37
Issue
7
Pages
1789-1796
ISSN
  • 0149-5992 (ISSN-L)
  • 1935-5548
OpenAlex
W2134076472
Cited by
178
References
2
FWCI
23.94
Type
journal article
Language
en
Open access
hybrid

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.